Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis

 Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis

Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis

Shots:

  • Abbott has received CE Mark for Navitor making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk
  • Navitor uses Abbott’s FlexNav delivery system along with a unique design for preventing blood leaking around the valve to provide a less invasive alternative to surgical aortic valve replacement. The device features a NaviSeal fabric cuff that works as with the cardiac cycle to eliminate the backflow of blood around the valve (PVL)
  • The Navitor valve paired with the FlexNav delivery system streamlines and simplifies TAVI procedures for physicians

Click here to­ read full press release/ article | Ref: Abbott | Image: Media Post

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post